Literature DB >> 11929800

High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.

Arnaud Jaccard1, Bruno Royer, Dominique Bordessoule, Jean-Claude Brouet, Jean-Paul Fermand.   

Abstract

We treated 5 patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome and multifocal bone lesions or diffuse bone marrow plasmacytic infiltration with high-dose therapy (HDT) and autologous blood stem cell transplantation. In all cases, the treatment produced remission of plasma cell proliferation associated with marked improvement in the patients' performance status, neurologic symptoms, and other manifestations of the syndrome. HDT with stem cell support should be investigated further as a therapeutic option in patients with POEMS syndrome and disseminated plasma cell dyscrasia.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11929800     DOI： 10.1182/blood.v99.8.3057

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  20 in total

1.  Case of POEMS syndrome associated with bilateral macular detachment resolved by autologous peripheral blood stem cell transplantation.

Authors:  Kyoko Okada; Shuichi Yamamoto; Yoshihiko Tsuyama; Satoshi Mizunoya
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

2.  Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation.

Authors:  M Vermeulen; M H J van Oers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10       Impact factor: 10.154

3.  High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

Authors:  Gordon Cook; Simona Iacobelli; Anja van Biezen; Dimitris Ziagkos; Veronique LeBlond; Julie Abraham; Grant McQuaker; Stefan Schoenland; Alessandro Rambaldi; Kazimierz Halaburda; Maria Rovira; Simona Sica; Jenny Byrne; Ramon Garcia Sanz; Arnon Nagler; Niels W C J van de Donk; Marjatta Sinisalo; Mark Cook; Nicolaus Kröger; Theo De Witte; Curly Morris; Laurant Garderet
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

4.  Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation.

Authors:  M Vermeulen; M H J van Oers
Journal:  BMJ Case Rep       Date:  2009-01-23

Review 5.  Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.

Authors:  Ajay Kumar; Karthikeyan Narayanan; Ravi Kumar Chaudhary; Sachin Mishra; Sundramurthy Kumar; Kumar Jayaseelan Vinoth; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

Review 6.  Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma.

Authors:  Motohiro Shindo; Kazuya Sato; Masayo Yamamoto; Yasumichi Toki; Mayumi Hatayama; Satoshi Ito; Kazuhiko Ichiki; Naoka Okamura; Takaaki Hosoki; Katsuya Ikuta; Junki Inamura; Shinji Watanabe; Yoshihiro Torimoto; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2011-05-07       Impact factor: 2.490

7.  Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue.

Authors:  Hiroshi Kojima; Yuna Katsuoka; Yukitaka Katsura; Sachie Suzuki; Kazumi Suzukawa; Yuichi Hasegawa; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

8.  Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure.

Authors:  Atsuko Y Higashi; Fumiaki Nogaki; Isoroku Kato; Takahiko Ono; Atsushi Fukatsu
Journal:  Clin Exp Nephrol       Date:  2011-10-08       Impact factor: 2.801

Review 9.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

10.  Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience.

Authors:  Il-Young Jang; Dok Hyun Yoon; Shin Kim; Kyoungmin Lee; Kwang-Kuk Kim; Young-Min Lim; Won-Ki Min; Cheolwon Suh
Journal:  Blood Res       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.